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Racial differencesAbstract Studies have shown an increased risk of breast cancer associated with
diabetes which may be due to differences in mammography use among women
who have diabetes compared with women who do not have diabetes. Baseline data
was used from the Southern Community Cohort Study – a prospective cohort study
conducted primarily among low-income persons in the southeastern United States –
to examine the association between diabetes and mammography use. In-person
interviews collected information on diabetes and mammography use from 14,665
white and 30,846 black women aged 40–79 years between 2002 and 2009. After
adjustment for potential confounding, white women with diabetes were no more
likely (odds ratio [OR] 0.95, 95% confidence interval [CI] 0.85–1.06) to undergo
mammography within the past 12 months than white women without diabetes.
Nor was there an association between diabetes and mammography use among black
women (OR 1.00, 95% CI 0.93–1.07). An increase in mammography use was seen
within one year following diabetes diagnosis, more so among white than black
women, but this was offset by decreases thereafter. Although there was some
224 M. Sanderson et al.evidence of an increase in mammography use within one year of diabetes diagnosis,
these results suggest that mammography use is not related to diabetes.
ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Meta-analyses of the association between diabetes
and breast cancer have reported a summary rela-
tive risks (RRs) of approximately 1.20, with 95%
confidence intervals (CIs) ranging from 1.12 to
1.30 [1–4]. Three of the four meta-analyses were
stratified by menopausal status at breast cancer
diagnosis, and reported an increased breast cancer
risk associated with diabetes among women diag-
nosed post-menopause, but not among women
diagnosed prior to menopause [2–4]. One of the
meta-analyses restricted to more recent studies
found stronger RRs in studies conducted among
European women (RR 1.88, 95% CI 1.56–2.25) than
among American women (RR 1.16, 95% CI 1.12–
1.20), and no association among Asian women (RR
1.01, 95% CI 0.84–1.21) [4]. The increase in post-
menopausal breast cancer risk associated with dia-
betes has been reported also in more recent, large
cohort studies conducted since the meta-analyses
[5]. In particular, Bowker and colleagues reported
that the risk for breast cancer diagnosed among
women at age 55 years or older, and presumably
postmenopausal, was non-significantly increased
for 0–3 months following a diagnosis of diabetes
(HR 1.31, 95% CI 0.92–1.86), but then returned to
baseline from 3 months to 10 years following the
diabetes diagnosis (HR 1.00, 95% CI 0.90–1.11)
[6]. The authors concluded that the initially ele-
vated post-menopausal breast cancer risk may
have been due to detection bias.
Possible explanations for the positive associa-
tion between diabetes and post-menopausal breast
cancer have included a direct effect of diabetes on
increased breast cancer growth by altering levels
of insulin, insulin-like growth factors and endoge-
nous sex hormones [3], residual confounding by
obesity [7], or an indirect effect due to differences
in mammography use among women who have dia-
betes compared with women who do not have dia-
betes [6]. Initial increases followed by reductions
in RRs with increasing time since diabetes diagnosis
have been reported for several other cancers (lung,
cervical, ovarian, pancreatic and prostate), but not
all cancers (colorectal, liver and endometrial)
examined and no pattern with regard to the avail-
ability of screening tests [8]. Three studies con-
ducted in the United States [9–11] and one inCanada [12] reported that women with diabetes
were less likely than women without diabetes to
have received a recent mammogram, but an analy-
sis restricted to black women [11] found no differ-
ence in mammography use by diabetes status. In
contrast, a previous study in the Southern Commu-
nity Cohort Study (SCCS) population that investi-
gated the association between obesity and
mammography use reported, for both blacks and
whites, a higher percentage of self-reported mam-
mography within the past two years among women
with diabetes (black 78.4%; white 71.5%) than
among women without diabetes (black 71.1%;
white 67.9%) [13]. In this SCCS-based study, after
adjustment for health insurance coverage and
other confounders, black women who were over-
weight or obese were more likely to have under-
gone recent mammography, while white women
who were obese were less likely. It was hypothe-
sized that recent mammography would be most
prevalent near the time of diabetes diagnosis,
and the association would differ among black and
white women. Unlike previous studies, adjust-
ments will be made for obesity in investigating
the associations of diabetes and mammography
use and the timing of mammography after diabetes
diagnosis.
2. Materials and methods
Detailed methods of the SCCS appear elsewhere
[14]. Briefly, the cohort included a total of
14,890 white women, 31,527 black women, and
2501 women of other racial/ethnic groups who en-
rolled between March 2002 and September 2009.
Approximately 88% of women completed in-person
interviews at Community Health Centers in 12
Southeastern States of the United States, with
the remaining women randomly sampled from the
general population and completing mailed ques-
tionnaires. Women of other racial/ethnic groups,
women with a history of breast cancer, and women
whose mammography history was not available
were excluded from the analysis, resulting in
14,665 white women, and 30,846 black women
for analysis.
Institutional Review Boards of the Vanderbilt
University and Meharry Medical College approved
this studys protocol. Trained interviewers con-
Table 1 Characteristics of white women who did and did not receive a mammogram within the past 12 months, Southern
Community Cohort Study, 2002–2009.
Characteristic Received
mammogram
Did not receive
mammogram
p-value
n % n %
Age (years) <0.0001
40–49 1451 30.2 4158 42.4
50–59 1830 38.1 3415 34.7
60–69 1200 25.0 1758 17.8
70–79 326 6.8 527 5.4
Total household income <0.0001
<$15,000 1835 38.9 5332 54.9
$15,000–$49,999 1777 37.7 3393 34.9
P$50,000 1101 23.3 994 10.2
Educational level <0.0001
<12 years 901 18.7 2668 27.1
Completed high school or GED 1452 30.2 3352 34.0
Vocational/some college 1327 27.6 2578 26.2
Graduated from college 1124 23.4 1259 12.8
Marital status <0.0001
Single 336 7.1 779 8.0
Married/living with a partner 2367 49.9 4203 42.9
Divorced/widowed/separated 2038 43.0 4809 49.1
Family history of breast cancer <0.0001
No 3826 84.7 8172 88.4
Yes 691 15.3 1078 11.7
Health insurance coverage <0.0001
None 1130 23.6 4221 43.0
Medicare/medicaid only 1218 25.4 2671 27.2
Any private/champus/other 2443 51.0 2925 29.8
Recruitment source <0.0001
Community health centers 3508 73.0 8427 85.5
General population 1299 27.0 1431 14.5
Body mass index (kg/m2) maximum <0.0001
<25 797 16.8 1439 14.8
25–29.99 1222 25.8 2277 23.4
30–39.99 1824 38.4 3735 38.4
P40 903 19.0 2285 23.5
Hypertension 0.05
No 2382 49.6 5057 51.3
Yes 2424 50.4 4796 48.7
Cholesterol medications <0.0001
No 3480 72.6 7747 78.7
Yes 1314 27.4 2099 21.3
Alcohol intake 0.05
No 837 17.7 1853 19.1
Yes 3883 82.3 7869 80.9
Menopausal status <0.0001
Premenopausal 972 20.3 2544 25.9
Post-menopausal 3818 79.7 7297 74.2
Hormone replacement therapy <0.0001
No 2248 47.0 6140 62.7
Yes 2537 53.0 3655 37.3
Moderate physical activity (hours per week during 30s) 0.06
0 116 2.5 227 2.4
0.01–4.99 102 2.2 149 1.5
P5 4472 95.4 9246 96.1
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Mammography use among women with and without diabetes 225
Table 1 (continued)
Characteristic Received
mammogram
Did not receive
mammogram
p-value
n % n %
Vigorous physical activity (hours per week during 30s) <0.0001
0 1226 26.2 2662 27.6
0.01–4.99 720 15.3 1081 11.2
P5 2741 58.5 5911 61.2
226 M. Sanderson et al.ducted in-person interviews with subjects who pro-
vided written informed consent. All variables in the
present analysis are based on self-report. Women
were considered to have diabetes if they reported
having been told by their doctor they had diabetes
or high blood sugar. Information on time since diag-
nosis (<1-year and then 5-year categories) and use
of diabetes medications (oral or insulin, results
were similar for both types of medication and were
collapsed) was used to further categorize diabetes.
Mammography use was categorized as having oc-
curred within the 12 months prior to entry into
the study. This study stratified by race a priori,
since a previous study reported a lower likelihood
of a recent mammogram among white diabetic pa-
tients than non-diabetic patients, but no associa-
tion among black women [11]. Potential
confounders of the diabetes and mammography
use associations included: age, total annual house-
hold income, educational level, marital status,
family history of breast cancer, health insurance
coverage, recruitment source, maximum BMI (kg/
m2) based on self-report, hypertension, cholesterol
medication use (previously associated with mam-
mography) [15], alcohol intake, menopausal status,
hormone replacement therapy, and leisure-time
moderate and vigorous physical activity in hours
per week during their 30s, as categorized in Tables
1 and 2. Based on previous studies of diabetes or
metabolic syndrome and breast cancer, meno-
pausal status [2–6,16], age [16] and maximum
BMI [16] were assessed as effect modifiers of the
diabetes and mammography use association prior
to being assessed as confounders. Health insurance
coverage was also examined as an effect modifier
since it was strongly associated with mammography
in this study. For the assessment of effect modifi-
cation, menopausal status was categorized as pre-
menopausal or postmenopausal, age was
categorized as <65 years or P65 years, maximum
BMI was categorized as <30 or P30, and health
insurance coverage was categorized as none or
any (Medicare/Medicaid/private/CHAMPUS/
other).Statistical analyses were performed in SAS ver-
sion 9.2. This study assessed statistically significant
(two-sided, p < 0.05) differences between women
with diabetes and women without diabetes for po-
tential confounders using chi-square tests. Uncon-
ditional logistic regression was used to estimate
the odds ratios (Ors) and 95% CIs for mammography
use associated with diabetes. Interaction terms,
the product of diabetes and the putative effect
modifiers (menopausal status, age, maximum BMI,
and health insurance coverage), were added to lo-
gistic regression models and likelihood ratio tests
were performed to test for effect modification.
Variables were considered confounders if their
addition to the model changed the unadjusted OR
by 10% or more.
3. Results
Table 1 presents demographic and other character-
istics of white women who did (n = 4807, 32.8%)
and did not (n = 9858) receive a mammogram in
the past 12 months. In comparison with women
who did not receive a mammogram, women who
did receive a mammogram tended to be older,
have a higher household income, have a higher
education level, be married or living with a part-
ner, have a family history of breast cancer, have
private health insurance, have a lower maximum
BMI, be taking cholesterol medications, be never
or former smokers, be post-menopausal, have ta-
ken hormone replacement therapy, and engaged
in less vigorous physical activity during their 30s.
With the exception of engaging in less moderate
physical activity during their 30s, similar patterns
were seen in comparing black women who did
(n = 9145, 29.6%) and did not receive a mammo-
gram (n = 21,701), as seen in Table 2.
Table 3 presents ORs for the association be-
tween diabetes measures and mammography with-
in the past 12 months among white and black
women. There was no evidence of effect modifica-
tion by menopausal status, age, maximum BMI, or
health insurance coverage so models are adjusted
Table 2 Characteristics of black women who did and did not receive a mammogram within the past 12 months, Southern
Community Cohort Study, 2002–2009.
Characteristic Received
mammogram
Did not receive
mammogram
p-value
n % n %
Age (years) <0.0001
40–49 3679 40.2 11,044 50.9
50–59 2434 37.6 7013 32.3
60–69 1571 17.2 2701 12.5
70–79 463 5.1 943 4.4
Total household income <0.0001
<$15,000 4833 53.6 13,240 61.8
$15,000–$49,999 3496 38.8 7406 34.6
P$50,000 686 7.6 784 3.7
Educational level <0.0001
<12 years 2411 26.4 6799 31.3
Completed high school or GED 2894 31.7 7234 33.4
Vocational/some college 2544 27.8 5595 25.8
Graduated from college 1288 14.1 2056 9.5
Marital status <0.0001
Single 1929 21.2 5659 26.2
Married/living with a partner 2671 29.4 5598 25.9
Divorced/widowed/separated 4502 49.5 10,368 47.9
Family history of breast cancer <0.0001
No 7416 88.0 17,690 90.6
Yes 1012 12.0 1871 9.4
Health insurance coverage <0.0001
None 2622 28.8 8950 41.4
Medicare/medicaid only 3255 35.7 7231 33.5
Any private/champus/other 3240 35.5 5439 25.2
Recruitment source <0.0001
Community health centers 8034 87.9 20,193 93.1
General population 1111 12.2 1508 7.0
Body mass index (kg/m2) maximum <0.0001
<25 667 7.5 2138 10.0
25–29.99 1850 20.6 4378 20.6
30–39.9 4187 46.5 9484 44.6
P40 2292 25.5 5287 24.8
Hypertension <0.0001
No 3089 33.8 8660 39.9
Yes 6053 66.2 13,035 60.1
Cholesterol medications <0.0001
No 7099 77.7 18,331 84.6
Yes 2033 22.3 3344 15.4
Alcohol intake <0.0001
No 2060 22.9 4351 20.3
Yes 6953 77.1 17,097 79.7
Menopausal status <0.0001
Premenopausal 2674 29.3 8335 38.5
Post-menopausal 6442 70.7 13,308 61.5
Hormone replacement therapy <0.0001
No 6386 70.1 17,399 80.4
Yes 2721 29.9 4240 19.6
Moderate physical activity (hours per week during 30s) 0.45
0 275 3.1 733 3.5
0.01–4.99 181 2.0 426 2.0
P5 8426 94.9 20,040 94.5
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Table 2 (continued)
Characteristic Received
mammogram
Did not receive
mammogram
p-value
n % n %
Vigorous physical activity (hours per week during 30s) 0.0002
0 2883 32.4 7406 34.8
0.01–4.99 1312 14.7 2877 13.5
P5 4714 52.9 10,977 51.6
Table 3 Odds ratio for receiving a mammogram within the past 12 months associated with diabetes among white and
black women, Southern Community Cohort Study, 2002–2009.
Characteristic Received
mammogram
Did not receive
mammogram
ORb 95% CI c
n % n %
White
Self-reported diabetes
No 3886 80.9 7814 79.3 1.0 Referent
Yes 919 19.1 2041 20.7 0.95 0.85–1.06
Missing 2 3
Times since diabetes diagnosis (years)a
<1 83 9.2 155 7.7 1.0 Referent
1–4 298 33.0 672 33.3 0.69 0.50–0.96
5–9 200 22.1 449 22.3 0.70 0.50–1.00
10–14 123 13.6 301 14.9 0.69 0.48–1.01
15–19 70 7.7 159 7.9 0.80 0.52–1.23
P20 130 14.4 281 13.9 0.78 0.53–1.14
Missing 15 24
Diabetes medicationsa
No 209 22.8 410 20.1 1.0 Referent
Yes 709 77.2 1630 79.9 0.83 0.67–1.04
Missing 1 1
Black
Self-reported diabetes
No 6704 73.3 16,547 76.3 1.0 Referent
Yes 2441 26.7 5144 23.7 1.00 0.93–1.07
Missing 0 10
Times since diabetes diagnosis (years)a
<1 186 7.8 384 7.6 1.0 Referent
1–4 709 29.8 1529 30.4 0.87 0.70–1.08
5–9 525 22.1 1029 20.5 0.92 0.74–1.15
10–14 360 15.1 796 15.9 0.80 0.63–1.01
15–19 210 8.8 462 9.2 0.78 0.60–1.02
P20 390 16.4 823 16.4 0.83 0.65–1.05
Missing 61 121
Diabetes medicationsa
No 321 13.2 677 13.2 1.0 Referent
Yes 2118 86.8 4463 86.8 0.91 0.77–1.07
Missing 2 4
a Among women with diabetes.
b Odds ratio adjusted for age, total annual household income, educational level, marital status, health insurance coverage,
recruitment source, maximum BMI, hypertension, cholesterol medications, alcohol intake, menopausal status, hormone
replacement therapy and leisure-time moderate and vigorous physical activity during their 30s.
c Confidence interval.
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of those without diabetes had received a mammo-
gram, compared with 31.0% of those with diabetes.
Overall, there was no association between self-re-
ported diabetes and mammography in white wo-
men (OR 0.95, 95% CI 0.85–1.06) which did not
differ by menopausal status (premenopausal OR
0.88, 95% CI 0.66–1.15; postmenopausal OR 0.96,
95% CI 0.86–1.09; p-value for interaction = 0.65)
(not shown). However, among women with diabe-
tes, mammography use was significantly less by
approximately 30% for 1–14 years relative to the
first year after the diabetes diagnosis. Instead of
restricting the time since diabetes diagnosis analy-
sis to diabetic patients, if those without diabetes
are used as the reference category, a non-signifi-
cant higher odds of mammography use within one
year of diabetes diagnosis is evident (OR 1.29,
95% CI 0.95–1.74) (not shown). There was little ef-
fect of the use of diabetes medications on recent
mammography among white women (OR 0.83,
95% CI 0.67–1.04).
Among black women, 28.8% of those without
diabetes and 32.2% of those with diabetes had re-
ceived a mammogram. As was seen in white wo-
men, there was no association between diabetes
and mammography use among black women (OR
1.00, 95% CI 0.93–1.07), but there was also no sig-
nificant association between mammography use
and time since diabetes diagnosis or use of diabe-
tes medications. However, similar to whites, a
non-significant higher odds ratio of mammography
use was observed within a year of diabetes diagno-
sis when compared against black women without
diabetes (OR 1.18, 95% CI 0.97–1.43) (not shown).
The diabetes and mammography use association
did not differ by menopausal status among black
women (premenopausal OR 1.01, 95% CI 0.88–
1.16; post-menopausal OR 0.99, 95% CI 0.92–
1.07; p-value for interaction = 0.24) (not shown).
4. Discussion
Although previous studies among whites have re-
ported lower mammography use among women
with diabetes compared with women without
diabetes [9–12], this study found no difference in
recent mammography use by diabetes status over-
all. These findings among blacks were similar to
those of McBean and Yu [11] in that women with
and without diabetes received recent mammogra-
phy with similar prevalence overall. It was not pos-
sible to categorize time-since-diabetes-diagnosis
any more finely than 1 year, but the higher mam-
mography use within a year of diabetes diagnosisfollowed thereafter by lower use (with 30% and
12% reductions in mammography use among whites
and blacks, respectively) is consistent with the
findings of Bowker et al. [6] who reported an ele-
vated postmenopausal breast cancer risk within
3 months of diabetes diagnosis that disappeared
with time following the diagnosis.
To further explore the racial difference in tim-
ing of mammography relative to diabetes diagno-
sis, a sensitivity analysis was performed restricted
to women who had been diagnosed with diabetes,
hypertension or high cholesterol and who received
a mammogram to determine whether the distribu-
tions were similar for the three chronic conditions
(not shown). Time between diagnosis and mam-
mography was categorized as less than one year
vs. one year or greater. The percentage of women
with hypertension (whites 7.9%, blacks 6.9%, p-
value = 0.014) and women with high cholesterol
(whites 13.0%, blacks 17.5%, p-value <0.0001)
who received a mammogram within one year of
diagnosis differed significantly by race, but the
direction of association with race differed for
hypertension and high cholesterol, while the per-
centage of women with diabetes who received a
mammogram within one year of diagnosis did not
differ significantly by race (whites 10.1%, blacks
9.4%, p-value = 0.298). The absence of a consis-
tent, systematic racial pattern for mammography
use following diagnosis of various chronic diseases
lends support to the validity of these findings.
Thus, higher mammography use in the short-term
following a diabetes diagnosis may account in part
for the slightly elevated breast cancer risk associ-
ated with diabetes among white women, but not
among black women.
A limitation of this study was the self-reporting
of mammography use and diabetes; however, a val-
idation sub-study of the SCCS found that over 95%
of self-reported diabetes could be confirmed
through a medical chart review [14]. Approxi-
mately one fourth of diabetes is undiagnosed, so
there may have been a misclassification of self-re-
ported diabetes status among those not reporting
diabetes [17]. Mammography histories were not
collected in this study and therefore the indication
for the mammogram was unknown, so there may
have been women receiving diagnostic rather than
screening mammograms. In addition, self-reported
dates of diabetes diagnosis or whether diabetes
was diagnosed within the year prior to entry into
the cohort preceding the recent mammography
was not validated. However, the correct temporal
sequence of diabetes preceding the mammography
is assured for the great majority of diabetes pa-
230 M. Sanderson et al.tients with greater than one year duration of
diabetes.
Study strengths included the large size of the
study and assessment of effect modification and
confounding. The numbers of women were suffi-
cient to investigate the associations between dia-
betes and mammography use in white and black
women separately. Menopausal status, age, maxi-
mum BMI and health insurance were assessed as
effect modifiers in an attempt to disentangle their
contribution to the diabetes and mammography
use association. These and other confounders were
adjusted to isolate the effect of diabetes on mam-
mography apart from its effect on access to care.
5. Conclusions
In conclusion, although there was some evidence of
higher mammography use within one year of diabe-
tes diagnosis, these results suggest that mammog-
raphy use is not related to diabetes. Possible
direct effects of diabetes on increased breast
cancer growth through causal pathways should
continue to be explored.
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